SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001640455-23-000047
Filing Date
2023-04-03
Accepted
2023-04-03 07:54:45
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC14D9C jnce04032023sc14d-9c.htm SC14D9C 24015
2 EX-99.1 jnce04032023exhibit991.htm EX-99.1 19881
3 image_0a.jpg GRAPHIC 11145
  Complete submission text file 0001640455-23-000047.txt   60903
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filed by) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Subject) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-89831 | Film No.: 23790663
SIC: 2836 Biological Products, (No Diagnostic Substances)